Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group Virology Laboratories

Journal of Clinical Microbiology

Volumn 34, Issue 11, 1996, Pages 2695-2701

  Yen Lieberman, Belinda ^a   Brambilla, Donald ^b   Jackson, Brooks ^a,n   Bremer, James ^c   Coombs, Robert ^d   Cronin, Mike ^e   Herman, Steven ^f   Katzenstein, David ^g   Leung, Shiela ^b   Lin, Hsiang Ju ^h   Palumbo, Paul ⁱ   Rasheed, Suraiya ^j   Todd, John ^k   Vahey, Maryanne ^l   Reichelderfer, Patricia ^m  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Organon Teknika Corporation   (United States)

^f HOFFMANN LA ROCHE INC   (United States)

^g STANFORD UNIVERSITY   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k NOVARTIS PHARMA AG   (Switzerland)

^l WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^m NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; GOOD LABORATORY PRACTICE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; QUALITY CONTROL; VIRUS DETECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 10244222758     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.11.2695-2701.1996     Document Type: Article

References (38)

1. Aoki-sei, S., R. Y. Yarchoan, S. Kageyama, D. T. Hoekzema, J. M. Pluda, K. M. Wyvill, S. Broder, and H. Mitsuya. 1992. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res. Hum. Retroviruses 8:1263-1270.
2. Busch, M. P., D. R. Henrard, I. K. Hewlett, W. F. Mchaffey, J. S. Epstein, J.-P. Allain, T. H. Lee, J. W. Mosley, and the Transfusion Safety Study Group. 1992. Poor sensitivity, specificity and reproducibility of detection of HIV-1 DNA in serum by polymerase chain reaction. J. Acquired Immune Defic. Syndr. 5:872-877.
3. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
4. Collier, A. C., R. W. Coombs, M. A. Fischl, P. R. Skolnik, D. Northfeldt, P. Boutin, C. J. Hooper, L. D. Kaplan, P. A. Volberding, L. G. Davis, D. R. Henrard, S. Weller, and L. Corey. 1993. Combination therapy with zidovudine and didanosine compared to zidovudine alone in human immunodeficiency virus type one infection. Ann. Intern. Med. 119:786-793.
5. Coombs, R. W. 1994. HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. Clin. Lab. Med. 14:301-311.
6. Defer, C., H. Agut, A. Garbarg-Chenon, M. Moncany, F. Morinet, D. Vignon, M. Mariotti, and J. J. Lefrere. 1992. Multicentre quality control of polymer-ase chain reaction for detection of HlV DNA. AIDS 6:659-663.
7. Dickover, R. E., E. M. Garrity, S. Herman, M. Sim, S. Plaeger, P. J. Boyer, M. Keller, A. Deveikis, E. R. Stiehm, and Y. Bryson. 1996. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 275:599-605.
8. Division of AIDS, National Institute of Allergy and Infectious Diseases. 1994. ACTG virology manual for HIV laboratories. Publication NIH-94-3828. U.S. Department of Health and Human Services, Washington, D.C.
9. Feldman, H. A. 1988. Families of lines: random effects in linear regression analysis. J. Appl. Physiol. 64:1721-1732.
10. Hammer, S., C. Crumpacker, R. D'Aquila, B. Jackson, J. Lathey, D. Livnat, and P. Reichelderfer. 1993. Use of virologie assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J. Clin. Microbiol. 31:2557-2564.
11. Henrard, D. R., W. F. Mehaffey, and J. P. Allain. 1992. A sensitive viral capture assay for detection of plasma viremia in HIV-infected individuals. AIDS Res. Hum. Retroviruses 8:47-52.
12. Henrard, D. R., J. F. Phillips, L. R. Muenz, W. A. Blattner, D. Wesner, M. E. Eyster, and J. J. Goedert. 1995. Natural history of HIV-1 cell-free viremia. JAMA 274:554-558.
13. Hogervost, E., S. Jurriaans, F. de Wolf, A. van Wijk, A. Wiersma, M. Valk, M. Roos, B. van Gemen, R. Coutinho, F. Miedema, and J. Goudsmit. 1995. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J. Infect. Dis. 171:811-821.
14. Hollinger, F. B., J. W. Bremer, L. E. Myers, J. W. M. Gold, L. McQuay, and the NIH/NIAID/DAIDS/ACTG Virology Laboratories. 1992. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J. Clin. Microbiol. 30:1787-1794.
15. Holodniy, M., D. A. Katzenstein, D. M. Israelski, and T. C. Merigan. 1991. Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction. J. Clin. Invest. 88:1755-1759.
16. Holodniy, M., D. A. Kalzenstein, and S. Sengupta. 1991. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J. Infect. Dis. 163:862-865.
17. + cell count and clinical diagnosis of AIDS, p. 67. In Third International Workshop on Drug Resistance.
18. Jackson, J. B., J. Drew, H. J. Lin, P. Otto, J. W. Bremer, F. B. Hollinger, S. M. Wolinsky, the ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. 1993. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. J. Clin. Microbiol. 31:3123-3128.
19. Larder, B. A., S. D. Kemp, and P. R. Harrigan. 1995. Potential mechanism for sustained efficacy of AZT-3TC combination therapy. Science 269:696-699.
20. Lin, H. J., M. Haywood, and F. B. Hollinger. 1996. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA. J. Clin. Microbiol. 34:329-333.
21. Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Vahey, M. A. Winters, L. J. McQuay, P. L. Nara, P. Reichelderfer, R. W. Coombs, and J. B. Jackson. 1994. Multicenter evaluation of methods for the quantitation of plasma HIV-1 RNA. J. Infect. Dis. 170:553-562.
22. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, J. A. Todd, B. S. Hoo, R. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
23. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
24. + lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334:426-431.
25. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, J. Kolberg, R. Kokka, P. Neuwald, and M. S. Urdea. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:446-454.
26. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Leifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
27. Revets, H., D. Marissens, S. De Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis. 1996. Comparative evaluation of NASBA HIV-1 RNA QT, Amplicor-HIV Monitor, and Quantiplex HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1058-1064.
28. + T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann. Intern. Med. 113:438-443.
29. Schuurman, R., and the Delta Virology Group. 1996. Multicenter comparison of three commercial methods for plasma HIV-1 RNA quantification using spiked human plasma and clinical plasma samples, abstr. 4542. In Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections.
30. Semple, M., C. Loveday, I. Weller, and R. Tedder. 1991. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J. Med. Virol. 35:38-45.
31. Sheppard, H. W., M. S. Ascher, M. P. Busch, P. R. Sohmer, M. Stanley, M. C. Luce, J. A. Chimera, R. Madej, G. C. Rodgers, C. Lynch, H. Khayam-Bashi, E. L. Murphy, B. Eble, W. Z. Bradford, R. A. Royce, and W. Winlestein, Jr. 1991. A multicenter proficiency trial of gene amplification (PCR) for the detection of HIV-1. J. Acquired Immune Defic. Syndr. 4:277-283.
32. Snedecor, G. W., and W. G. Cochran. 1967. Statistical methods. Iowa State University Press, Ames.
33. Vahey, M., and M. T. Wong. 1995. A quantitative liquid hybridization polymerase chain reaction methodology employing storage phosphor technology, p. 313-338. In C. Diffenbach and G. Dveksler (ed.), The Cold Spring Harbor laboratory manual for PCR. Cold Spring Harbor Press, Cold Spring Harbor, New York.
34. Vahey, M. T., D. L. Mayers, K. F. Wagner, R. C. Y. Chung, O. S. Weislow, S. Zhou, D. S. Burke, and RV43 Study Group. 1994. Plasma HIV RNA predicts clinical outcome on AZT therapy, abstr. 253B. In Abstracts of the Tenth International Conference on AIDS.
35. van Gemen, B., T. Kievits, R. Schukkink, D. van Strijp, L. T. Malek, R. Sooknanan, H. G. Huisman, and P. Lens. 1993. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J. Virol. Methods 43:177-188.
36. Weiser, B., S. Nachman, P. Tropper, K. H. Viscosi, R. Grimson, G. Baxter, and G. Fang. 1994. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc. Natl. Acad. Sci. USA 91:8037-8041.
37. Winters, M. A., L. B. Tan, D. A. Katzenstein, and T. C. Merigan. 1993. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 31:2960-2966.
38. Yerly, S., L. Kaiser, B. Mermillod, et al. 1995. Response of HIV RNA to didanosine as a predictive marker of survival. AIDS 9:159-163.